FDA — authorised 15 December 2015
- Application: NDA022225
- Marketing authorisation holder: MSD SUB MERCK
- Local brand name: BRIDION
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 deep block in United States
FDA authorised deep block on 15 December 2015
Marketing authorisations
FDA
- Status: approved
deep block in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is deep block approved in United States?
Yes. FDA authorised it on 15 December 2015; FDA has authorised it.
Who is the marketing authorisation holder for deep block in United States?
MSD SUB MERCK holds the US marketing authorisation.